Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 25;4(1):e190.
doi: 10.1017/ash.2024.420. eCollection 2024.

SARS-CoV-2 seropositivity among healthcare professionals in a rural state

Affiliations

SARS-CoV-2 seropositivity among healthcare professionals in a rural state

Brianna Wright et al. Antimicrob Steward Healthc Epidemiol. .

Abstract

Objectives: We evaluated SARS-CoV-2 anti-nucleocapsid (anti-N) seroconversion and seroreversion rates, risk factors associated with SARS-CoV-2 seroconversion, and COVID-19 risk perceptions among academic healthcare center employees in a rural state.

Methods: Among employees aged ≥18 years who completed a screening survey (n = 1,377), we invited all respondents reporting previous COVID-19 (n = 85; 82 accepted) and a random selection of respondents not reporting previous COVID-19 (n = 370; 220 accepted) to participate. Participants completed surveys and provided blood samples at 3-month intervals (T0, T3, T6, T9). We used logistic regression to identify risk factors for seropositivity at T0.

Results: The cohort was primarily direct patient caregivers (205/302; 67.9%), white (278/302; 92.1%), and female (212/302; 70.2%). At T0, 86/302 (28.4%) participants were seropositive. Of the seronegative participants, 6/198 (3.0%), 6/183 (3.3%), and 14/180 (7.8%) had seroconverted at T3, T6, and T9, respectively. The overall seroreversion rate was 6.98% at T9. At T0, nursing staff (odds ratio [OR], 2.37; 95% confidence interval [CI], 1.08, 5.19) and being within six feet of a non-household member outside of work (OR, 2.91; 95% CI, 1.02, 8.33) had significantly higher odds of seropositivity. Vaccination (OR, 0.05; 95% CI, 0.02, 0.12) and face mask use (OR, 0.36; 95% CI, 0.17, 0.78) were protective.

Conclusions: The seroconversion and seroreversion rates were low among participants. Public health and infection prevention measures implemented early in the COVID-19 pandemic - vaccination, face mask use, and social distancing - were associated with significantly lower odds of SARS-CoV-2 seropositivity among participants.

PubMed Disclaimer

Conflict of interest statement

BW, DK, AS, MAW, MDK, AMS, and JC report no conflicts of interest relevant to this article. DJD reports research funding from BioMerieux, Inc. and Affinity Biosensors. LH reports having receiving povidone iodine product for unrelated clinical trials from 3M and from PDI.

Figures

Figure 1.
Figure 1.
Seroconversions during Different Phases of the Pandemic. UIHC, University of Iowa Hospitals and Clinics. To assess COVID-19 seroconversion data in the context of vaccine availability and the circulating variants, we defined the time variable shown on the x-axis as the number of days since the first case of COVID-19 was identified in Iowa (March 8, 2020).
Figure 2.
Figure 2.
Changes in Healthcare Professionals’ Perceptions of COVID-19 Over Time. (a). Healthcare Professionals’ Concern about Spreading COVID-19 if Infected but Asymptomatic. (b). Healthcare Professionals’ Willingness to Visit Public Places. (c). Healthcare Professionals’ Face Covering Use in Public Places Outside of Work. To assess COVID-19 sentiment data in the context of vaccine availability and the circulating variants, we defined the time variable shown on the x-axis as the number of days since the first case of COVID-19 was identified in Iowa (March 8, 2020).

Similar articles

References

    1. Beh CC, Zulkufli NS, Loh LM, et al. SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees. Trop Biomed 2021;38:552–560. doi: 10.47665/tb.38.4.098 - DOI - PubMed
    1. Brousseau N, Morin L, Ouakki M, et al. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study. CMAJ 2021;193:E1868–E1877. doi: 10.1503/cmaj.202783 - DOI - PMC - PubMed
    1. Bryan A, Tatem K, Diuguid-Gerber J, et al. Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York. BMJ Open 2021;11:e053158. doi: 10.1136/bmjopen-2021-053158 - DOI - PMC - PubMed
    1. Plebani M, Padoan A, Fedeli U, et al. SARS-CoV-2 serosurvey in health care workers of the Veneto Region. Clin Chem Lab Med 2020;58:2107–2111. doi: 10.1515/cclm-2020-1236 - DOI - PubMed
    1. Moscola J, Sembajwe G, Jarrett M, et al. Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York city area. JAMA 2020;324:893–895. doi: 10.1001/jama.2020.14765 - DOI - PMC - PubMed

LinkOut - more resources